ArticleAmerican journal of public health2023
State-Level History of Overdose Deaths Involving Stimulants in the United States, 1999‒2020.
Abstract read
In one paragraph
Article in American journal of public health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed.
- US drug overdose deaths involving stimulants without opioids continued to rise in 2024.Addictive behaviors reports · 2026Article
- Drug Use and Social Connectivity Related to Hepatitis C Infection Among Rural People Who Use Drugs.Journal of viral hepatitis · 2026Article
- Higher drug overdose mortality among non-hispanic black adults aged 55 and older in the U.S.: Analysis of national death records from CDC's WONDER database (1999-2023).Drug and alcohol dependence reports · 2026Article
- The Polysubstance Assessment Tool: Reliability, acceptability and feasibility of a novel measure of polysubstance use.Addiction (Abingdon, England) · 2026Article
- Enhancing data compatibility in an evolving landscape: Medical cannabis and polysubstance use protocols in the PhenX Toolkit.Drug and alcohol dependence · 2026Article
- Fentanyl Research: Key to Fighting the Opioid Crisis.Journal of clinical medicine · 2025Article
- Introduction to the special section on polysubstance use: Emerging trends, psychosocial drivers, and treatment challenges.The International journal on drug policy · 2025Article
- Synthetic Opioid and Stimulant Co-Involved Overdose Deaths by Occupation and Industry - United States, 2022.MMWR. Morbidity and mortality weekly report · 2025Article
- Article
- "I Been Taking Adderall Mixing it With Lean, Hope I Don't Wake Up Out My Sleep": Harnessing Twitter to Understand Nonmedical Prescription Stimulant Use among Black Women and Men Subscribers.medRxiv : the preprint server for health sciences · 2024Article
- Article
- "I Can Combine Those Things to be a Superhero" a Qualitative Study of the Motivations for High-Risk Polysubstance Use.Journal of drug issues · 2024Article
- Unmet needs and harm reduction preferences of syringe services program participants: differences by co-use of illicit opioids and methamphetamine.Harm reduction journal · 2024Article
- The impact of fentanyl on state- and county-level psychostimulant and cocaine overdose death rates by race in Ohio from 2010 to 2020: a time series and spatiotemporal analysis.Harm reduction journal · 2024Article
- Article
Corrections and comments
- Commented on by
Authors and funding
6 authors.
David KlineDavid Kline is with the Department of Biostatistics and Data Science, Wake Forest University (WFU) School of Medicine, Winston-Salem, NC. Amanda M. Bunting, Ariadne Rivera-Aguirre, Noa Krawczyk, and Magdalena Cerda are with the Center for Opioid Epidemiology and Policy, Department of Population Health, New York University (NYU) Langone School of Medicine, New York, NY. Staci A. Hepler is with the Department of Statistical Sciences, Wake Forest University.
Amanda M BuntingDavid Kline is with the Department of Biostatistics and Data Science, Wake Forest University (WFU) School of Medicine, Winston-Salem, NC. Amanda M. Bunting, Ariadne Rivera-Aguirre, Noa Krawczyk, and Magdalena Cerda are with the Center for Opioid Epidemiology and Policy, Department of Population Health, New York University (NYU) Langone School of Medicine, New York, NY. Staci A. Hepler is with the Department of Statistical Sciences, Wake Forest University.
Staci A HeplerDavid Kline is with the Department of Biostatistics and Data Science, Wake Forest University (WFU) School of Medicine, Winston-Salem, NC. Amanda M. Bunting, Ariadne Rivera-Aguirre, Noa Krawczyk, and Magdalena Cerda are with the Center for Opioid Epidemiology and Policy, Department of Population Health, New York University (NYU) Langone School of Medicine, New York, NY. Staci A. Hepler is with the Department of Statistical Sciences, Wake Forest University.
Ariadne Rivera-AguirreDavid Kline is with the Department of Biostatistics and Data Science, Wake Forest University (WFU) School of Medicine, Winston-Salem, NC. Amanda M. Bunting, Ariadne Rivera-Aguirre, Noa Krawczyk, and Magdalena Cerda are with the Center for Opioid Epidemiology and Policy, Department of Population Health, New York University (NYU) Langone School of Medicine, New York, NY. Staci A. Hepler is with the Department of Statistical Sciences, Wake Forest University.
Noa KrawczykDavid Kline is with the Department of Biostatistics and Data Science, Wake Forest University (WFU) School of Medicine, Winston-Salem, NC. Amanda M. Bunting, Ariadne Rivera-Aguirre, Noa Krawczyk, and Magdalena Cerda are with the Center for Opioid Epidemiology and Policy, Department of Population Health, New York University (NYU) Langone School of Medicine, New York, NY. Staci A. Hepler is with the Department of Statistical Sciences, Wake Forest University.
Magdalena CerdaDavid Kline is with the Department of Biostatistics and Data Science, Wake Forest University (WFU) School of Medicine, Winston-Salem, NC. Amanda M. Bunting, Ariadne Rivera-Aguirre, Noa Krawczyk, and Magdalena Cerda are with the Center for Opioid Epidemiology and Policy, Department of Population Health, New York University (NYU) Langone School of Medicine, New York, NY. Staci A. Hepler is with the Department of Statistical Sciences, Wake Forest University.
Funding
Spatio-temporal Methods for Surveillance of the Opioid SyndemicR01DA052214 · NIDA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI HEPLER, STACI, KLINE, DAVID M · 2021 to 2025
$3.7MThe Lifespan/Brown Criminal Justice Research Program on Substance Use and HIVR25DA037190 · NIDA · MIRIAM HOSPITAL · PI CURT G BECKWITH · 2014 to 2026
$3.5MDevelopment of a novel polysubstance assessment tool for vulnerable subpopulationsK01DA053435 · NIDA · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI BUNTING, AMANDA M · 2021 to 2025
$909kBeyond Treatment Initiation: Enhancing Opioid Use Disorder Care Transitions Across Health System TouchpointsK01DA055758 · NIDA · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI Noa Krawczyk · 2023 to 2026
$722kNIDA NIH HHS K01 DA053435NIDA NIH HHS K01 DA055758NIDA NIH HHS R01 DA052214NIDA NIH HHS R25 DA037190
Abstract
PubMed holds no abstract for this paper.
Indexed as
Central Nervous System StimulantsCocaineDrug OverdoseAnalgesics, OpioidAppalachian RegionBayes TheoremHumansUnited StatesAnalgesics, OpioidCentral Nervous System StimulantsCocaine
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.